Trump's tariffs and a shrinking market for alcohol deal double blow to Diageo
Donald Trump's tariffs are a further headache for drinks giant Diageo, which is already being buffeted by a decline in alcohol consumption.

More bad news for drinks giant Diageo, says Jessica Newman in The Times. It has announced that the spectre of US tariffs and uncertainty in many of its markets had forced it to jettison a longstanding revenue growth target. Since 2021, the world’s largest producer of spirits has been targeting yearly organic sales growth of between 5% and 7% over the medium term. However, while the tariffs on goods imported to the US from Mexico were delayed by a month at the last minute, the company says the chance they may yet be imposed “adds further complexity” to its ability to predict future trading.
Diageo is right to be “cautious”, says eToro’s Adam Vettese. After all, the company is particularly exposed to the “spectre of tariffs” given that it imported $1.6 billion worth of tequila into the US last year. While Diageo has said it will take measures to temper the impact of 25% tariffs, there is a limit to what cost-cutting and inventory management can do when faced with such a “mammoth additional expense”. Although Diageo’s shares have struggled in recent months, “it’s difficult to bet against the price falling even further” if Trump follows through.
Diageo's toxic cocktail
Tariffs aren’t the only issue causing “disquiet”, says Rob Davies in The Guardian. While Diageo’s share price reached a peak of £40 in early 2022, the company has since been hit by a “shock profits warning” and “adverse global consumer trends”. The stock is now on £23, near a seven-year trough. What’s more, longtime investor Terry Smith recently revealed his fund had dumped its stake in the company owing to his concerns that drinks companies were losing their defensive status, in addition to specific concerns about Diageo’s management.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Even taking Donald Trump’s threatened trade frictions out of the equation, Diageo’s “heavy debt load and lacklustre growth” pose a major problem for the company’s future, says Aimee Donnellan on Breakingviews. Diageo’s adjusted net debt to Ebitda ratio is 3.1, a sharp rise from 2.3 in 2019. The need to get this down to a more sensible level may force CEO Debra Crew either to sacrifice investment, which could hamper growth, or sell assets in what is already a “pretty dire” market for drinks brands.
Nonetheless, at least Diageo’s shareholders aren’t alone in their misery, say Madeleine Speed and Harriet Agnew in the Financial Times. Growth in the wider drinks industry has stagnated as drinkers have reduced their alcohol intake “following an unprecedented boom during Covid-19 and the ensuing recovery”. Recent comments by the US surgeon-general that alcoholic drinks should carry a cancer warning, worries that weight-loss drugs may also be able to reduce alcohol consumption, and a growing trend towards moderation have “also caused jitters”. As a result, all spirits stocks have been “hammered”, with the sector now “trading at a significant discount to the wider consumer category”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Zelenskyy moves to appease Donald Trump – what happens now?
Ukraine’s president Volodymyr Zelenskyy is conceding ground to secure the least-worst deal possible, says Emily Hohler
By Emily Hohler Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fades
Food-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
By Dr Matthew Partridge Published
-
Should investors stay bullish and buy UK and US stocks?
Opinion Ignore the Eeyores, says Max King. The outlook for stocks in both Britain and America remains auspicious
By Max King Published